Traders Sell Thermo Fisher Scientific Inc. (TMO) on Strength (TMO)
Traders sold shares of Thermo Fisher Scientific Inc. (NYSE:TMO) on strength during trading hours on Friday. $25.88 million flowed into the stock on the tick-up and $47.34 million flowed out of the stock on the tick-down, for a money net flow of $21.46 million out of the stock. Of all equities tracked, Thermo Fisher Scientific had the 0th highest net out-flow for the day. Thermo Fisher Scientific traded up $1.09 for the day and closed at $157.51
Several analysts recently issued reports on the company. BTIG Research raised Thermo Fisher Scientific from a “neutral” rating to a “buy” rating and set a $180.00 target price on the stock in a research note on Friday, July 22nd. Citigroup Inc. raised their price objective on shares of Thermo Fisher Scientific from $160.00 to $182.00 and gave the stock a “buy” rating in a report on Friday, July 29th. Leerink Swann restated a “buy” rating on shares of Thermo Fisher Scientific in a report on Sunday, May 29th. Jefferies Group restated a “hold” rating on shares of Thermo Fisher Scientific in a report on Thursday. Finally, Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Friday. Two analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Thermo Fisher Scientific has an average rating of “Buy” and a consensus price target of $159.66.
The company has a 50 day moving average price of $152.98 and a 200-day moving average price of $143.93. The company has a market capitalization of $62.04 billion and a price-to-earnings ratio of 31.51.
Thermo Fisher Scientific (NYSE:TMO) last issued its earnings results on Thursday, July 28th. The company reported $2.03 EPS for the quarter, topping the Zacks’ consensus estimate of $2.01 by $0.02. During the same quarter in the prior year, the company earned $1.84 earnings per share. The company earned $4.54 billion during the quarter, compared to the consensus estimate of $4.50 billion. Thermo Fisher Scientific’s revenue was up 6.2% on a year-over-year basis. On average, analysts expect that Thermo Fisher Scientific Inc. will post $8.15 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Shareholders of record on Thursday, September 15th will be paid a $0.15 dividend. The ex-dividend date is Tuesday, September 13th. This represents a $0.60 dividend on an annualized basis and a yield of 0.38%.
In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 20,000 shares of the company’s stock in a transaction dated Tuesday, July 5th. The shares were sold at an average price of $147.69, for a total value of $2,953,800.00. Following the transaction, the chief executive officer now directly owns 340,998 shares in the company, valued at approximately $50,361,994.62. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Thomas W. Loewald sold 8,025 shares of the company’s stock in a transaction dated Wednesday, July 13th. The stock was sold at an average price of $155.00, for a total transaction of $1,243,875.00. Following the completion of the transaction, the senior vice president now owns 52,194 shares in the company, valued at $8,090,070. The disclosure for this sale can be found here.
Other institutional investors have added to or reduced their stakes in the company. Haverford Trust Co. increased its position in Thermo Fisher Scientific by 0.5% in the fourth quarter. Haverford Trust Co. now owns 7,334 shares of the company’s stock worth $1,040,000 after buying an additional 34 shares in the last quarter. Cambridge Investment Research Advisors Inc. increased its position in Thermo Fisher Scientific by 16.2% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 7,334 shares of the company’s stock worth $1,040,000 after buying an additional 1,022 shares in the last quarter. Ameritas Investment Partners Inc. increased its position in Thermo Fisher Scientific by 2.7% in the fourth quarter. Ameritas Investment Partners Inc. now owns 7,665 shares of the company’s stock worth $1,086,000 after buying an additional 204 shares in the last quarter. UBS Oconnor LLC acquired a new position in Thermo Fisher Scientific during the fourth quarter worth about $1,277,000. Finally, Argent Trust Co increased its position in Thermo Fisher Scientific by 0.8% in the third quarter. Argent Trust Co now owns 10,619 shares of the company’s stock worth $1,299,000 after buying an additional 80 shares in the last quarter.
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.